BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
5.30
-0.27 (-4.85%)
Aug 14, 2025, 11:19 AM - Market open
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $9.52 million as of August 14, 2025. Its market cap has increased by 10.87% in one year.
Market Cap
9.52M
Enterprise Value
6.63M
1-Year Change
10.87%
Ranking
Category
Stock Price
$5.30
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $9.52M, a decrease of -77.39%. That is a compound annual growth rate of -26.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 10.01M | 99.12% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 223.20B |
| BHP Group | 138.42B |
| Rio Tinto Group | 107.16B |
| The Sherwin-Williams Company | 90.28B |
| Southern Copper | 80.65B |
| Ecolab | 79.28B |
| Newmont | 76.07B |
| CRH plc | 75.72B |